• Phos binding reagent (Phosbind) acrylamide for SDS-PAGE Phos

  2026-05-19

  Phos binding reagent (Phosbind) acrylamide enables antibody-free detection of protein phosphorylation via SDS-PAGE, offering a practical solution where phospho-specific antibodies are unavailable or insufficient. It is optimal for analyzing proteins between 30–130 kDa but should not be used for targets outside this range or where long-term reagent storage is unavoidable.

• Bufuralol Hydrochloride in Cardiovascular Pharmacology Resea

  2026-05-18

  Bufuralol hydrochloride is redefining β-adrenergic modulation in advanced in vitro and organoid-based cardiovascular studies. By integrating this non-selective β-adrenergic receptor antagonist into hiPSC-derived intestinal organoid workflows, scientists achieve superior pharmacokinetic and mechanistic insights while troubleshooting common assay pitfalls with confidence.

• Anti-b Suppresses mTOR/PPARγ and mTOR/SREBP1 to Treat Hyperl

  2026-05-18

  This study identifies Anti-b as a promising low molecular weight compound that mitigates hyperlipidaemia and hepatic steatosis in animal and cellular models. Anti-b acts by directly binding and inhibiting mTOR, leading to downregulation of PPARγ and SREBP1 signaling—key pathways in lipid metabolism—thereby reducing lipid accumulation and hepatic fat content.

• Protein A/G Magnetic Beads: Technical Guide for Purification

  2026-05-17

  Protein A/G Magnetic Beads address the challenge of efficient, low-background antibody purification and protein-protein interaction analysis from complex biological samples. They are best suited for immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows that require high specificity. Use is not recommended for diagnostic or therapeutic purposes, nor for applications outside research requiring non-IgG capture.

• AI Analysis of Urine Stem Cell Mitochondria as AD Biomarker

  2026-05-16

  This study introduces a deep learning approach to non-invasively assess mitochondrial morphology in urine-derived stem cells, enabling early detection of Alzheimer's disease (AD)–related dysfunction. The method leverages live-cell imaging and robust neural network classification to distinguish patterns linked to cognitive impairment, offering a scalable biomarker strategy.

• CRISPR-Cas9 Editing of LGMN Suppresses Breast Cancer Metasta

  2026-05-15

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs targeting the LGMN gene via lipid nanoparticles impairs breast cancer cell metastasis both in vitro and in vivo. The approach leverages in vitro transcription strategies for precise RNA synthesis, highlighting a promising direction for RNA-based genome editing against metastatic tumors.

• BIIE 0246 in Neuro-Adipose Signaling: Precision Tools for Me

  2026-05-15

  Explore BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, as a precision research tool for dissecting neuro-adipose signaling. This article delivers a deeper analysis of assay design and translational implications, setting it apart in the field.

• Streptavidin-FITC: Precision Fluorescent Detection in Biotin

  2026-05-14

  Streptavidin-FITC from APExBIO unlocks high-sensitivity, quantitative detection of biotinylated molecules across immunofluorescence, flow cytometry, and advanced nanoparticle tracking. Discover how its robust binding, workflow flexibility, and proven protocol enhancements deliver reproducibility and clarity in even the most demanding intracellular trafficking studies.

• QPRT Drives Breast Cancer Invasion via PLC Signaling Modulat

  2026-05-14

  Liu et al. (2021) reveal that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer invasiveness by promoting myosin light chain phosphorylation through the PLC signaling pathway. Their mechanistic dissection demonstrates that both genetic and pharmacologic targeting of QPRT or downstream PLC can mitigate invasive phenotypes, offering new insights for translational strategies in cancer metastasis research.

• Bufuralol (hydrochloride): Optimizing β-Adrenergic Modulatio

  2026-05-13

  This article delivers scenario-driven strategies for leveraging Bufuralol (hydrochloride) (SKU C5043) in cell-based and organoid assays, focusing on reproducibility, protocol clarity, and validated data interpretation. With a collegial, evidence-backed approach, it guides biomedical researchers through key experimental challenges and demonstrates the practical benefits of this non-selective β-adrenergic receptor antagonist from APExBIO.

• Latrunculin B Inhibitor: Precision Tools for Actin Dynamics

  2026-05-13

  Latrunculin B empowers short-term, high-fidelity disruption of actin cytoskeleton dynamics, making it indispensable for cellular actin dynamics research and cytoskeletal organization studies. Leveraging APExBIO’s rigorously validated compound, researchers achieve transient, reproducible results while minimizing off-target effects through optimized protocols and troubleshooting strategies.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-12

  Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with superior anti-angiogenic and anti-proliferative properties. Preclinical data confirm nanomolar inhibition of VEGFR2, PDGFRβ, and FGFR1, with favorable pharmacokinetic and safety profiles. Its unique selectivity and robust functional effects make it a valuable tool for angiogenesis and cancer research.

• Optimizing Sulfaphenazole Derivatives for Safer Antitubercul

  2026-05-12

  This study presents a systematic approach to modifying sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP2C9 inhibition. The findings highlight promising lead compounds with lower drug-drug interaction risk, offering a strategic advance in tuberculosis drug design.

• Protein A/G Magnetic Beads: Practical Guide for Immunoprecip

  2026-05-11

  Protein A/G Magnetic Beads (SKU K1305) streamline antibody purification and protein interaction studies by enabling rapid, low-background isolation from complex samples. These recombinant Protein A and Protein G beads are best applied to immunoprecipitation, co-IP, and Ch-IP workflows. Not intended for diagnostic use or sample types outside the antibody-based assay domain.

• Puromycin Dihydrochloride in Precision Ribosome and Cell Eng

  2026-05-11

  Explore how Puromycin dihydrochloride, a leading aminonucleoside antibiotic, is redefining ribosome function analysis and advanced cell engineering. This in-depth article provides new insights beyond standard selection protocols, bridging molecular mechanism with cutting-edge gene therapy strategies.

497 records 14/34 page Previous Next First page 上5页 1112131415 下5页 Last page